BR112019001178A2 - biotinas e composição de biotina - Google Patents
biotinas e composição de biotinaInfo
- Publication number
- BR112019001178A2 BR112019001178A2 BR112019001178-1A BR112019001178A BR112019001178A2 BR 112019001178 A2 BR112019001178 A2 BR 112019001178A2 BR 112019001178 A BR112019001178 A BR 112019001178A BR 112019001178 A2 BR112019001178 A2 BR 112019001178A2
- Authority
- BR
- Brazil
- Prior art keywords
- biotins
- biotin
- biotin composition
- composition
- relates
- Prior art date
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title abstract 6
- 235000020958 biotin Nutrition 0.000 title abstract 5
- 229960002685 biotin Drugs 0.000 title abstract 3
- 239000011616 biotin Substances 0.000 title abstract 3
- 150000001615 biotins Chemical class 0.000 title abstract 2
- 208000007386 hepatic encephalopathy Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305989.2A EP3275439A1 (en) | 2016-07-29 | 2016-07-29 | Method for treating hepatic encephalopathy |
| EP16305989.2 | 2016-07-29 | ||
| PCT/EP2017/069194 WO2018020010A1 (en) | 2016-07-29 | 2017-07-28 | Method for treating hepatic encephalopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019001178A2 true BR112019001178A2 (pt) | 2019-04-30 |
Family
ID=56618106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019001178-1A BR112019001178A2 (pt) | 2016-07-29 | 2017-07-28 | biotinas e composição de biotina |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10117854B2 (https=) |
| EP (2) | EP3275439A1 (https=) |
| JP (1) | JP2019522030A (https=) |
| KR (1) | KR20190034550A (https=) |
| AU (1) | AU2017303346A1 (https=) |
| BR (1) | BR112019001178A2 (https=) |
| CA (1) | CA3031302A1 (https=) |
| CY (1) | CY1122348T1 (https=) |
| DK (1) | DK3319601T3 (https=) |
| EA (1) | EA201990413A1 (https=) |
| ES (1) | ES2751154T3 (https=) |
| HK (1) | HK1254833B (https=) |
| HR (1) | HRP20191798T1 (https=) |
| HU (1) | HUE046590T2 (https=) |
| IL (1) | IL264460B (https=) |
| LT (1) | LT3319601T (https=) |
| MA (1) | MA42419B1 (https=) |
| ME (1) | ME03520B (https=) |
| PL (1) | PL3319601T3 (https=) |
| PT (1) | PT3319601T (https=) |
| RS (1) | RS59300B1 (https=) |
| SI (1) | SI3319601T1 (https=) |
| SM (1) | SMT201900628T1 (https=) |
| WO (1) | WO2018020010A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3275439A1 (en) * | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
| MX387893B (es) * | 2018-04-18 | 2025-03-19 | Alparis Sa De Cv | Nuevas fases solidas de rifaximina. |
| CN116173182A (zh) * | 2023-03-31 | 2023-05-30 | 苏州融析生物科技有限公司 | 醋酸格拉替雷药物组合物在肝硬化预防及治疗药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0788304B2 (ja) * | 1988-03-05 | 1995-09-27 | 三生製薬株式会社 | 高アンモニア血症治療剤 |
| US5814650A (en) * | 1992-09-28 | 1998-09-29 | Lifegroup S.P.A. | Biotin amides able to control glucidic metabolisms under dysmetabolic conditions and relative therapeutical compositions |
| DE20202562U1 (de) * | 2002-02-19 | 2002-05-23 | Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld | Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika |
| US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
| MX2012007365A (es) | 2009-12-23 | 2012-08-15 | Lupin Ltd | Composiciones farmaceuticas de liberacion lenta de iloperidona. |
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
| CA2910717C (en) | 2013-04-29 | 2021-01-26 | Assistance Publique - Hopitaux De Paris | Biotin for use in treating x-linked adrenoleukodystrophy |
| EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
| CN105614851A (zh) * | 2015-12-27 | 2016-06-01 | 劲膳美生物科技股份有限公司 | 肝性脑病医学配方食品 |
| EP3275439A1 (en) * | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
-
2016
- 2016-07-29 EP EP16305989.2A patent/EP3275439A1/en not_active Ceased
-
2017
- 2017-07-28 JP JP2019504740A patent/JP2019522030A/ja not_active Ceased
- 2017-07-28 AU AU2017303346A patent/AU2017303346A1/en not_active Abandoned
- 2017-07-28 DK DK17742782T patent/DK3319601T3/da active
- 2017-07-28 SI SI201730093T patent/SI3319601T1/sl unknown
- 2017-07-28 HK HK18113925.3A patent/HK1254833B/en not_active IP Right Cessation
- 2017-07-28 SM SM20190628T patent/SMT201900628T1/it unknown
- 2017-07-28 HU HUE17742782A patent/HUE046590T2/hu unknown
- 2017-07-28 KR KR1020197002991A patent/KR20190034550A/ko not_active Withdrawn
- 2017-07-28 LT LT17742782T patent/LT3319601T/lt unknown
- 2017-07-28 EA EA201990413A patent/EA201990413A1/ru unknown
- 2017-07-28 ME MEP-2019-267A patent/ME03520B/me unknown
- 2017-07-28 CA CA3031302A patent/CA3031302A1/en not_active Abandoned
- 2017-07-28 EP EP17742782.0A patent/EP3319601B1/en active Active
- 2017-07-28 WO PCT/EP2017/069194 patent/WO2018020010A1/en not_active Ceased
- 2017-07-28 RS RSP20191218 patent/RS59300B1/sr unknown
- 2017-07-28 MA MA42419A patent/MA42419B1/fr unknown
- 2017-07-28 PT PT17742782T patent/PT3319601T/pt unknown
- 2017-07-28 BR BR112019001178-1A patent/BR112019001178A2/pt not_active IP Right Cessation
- 2017-07-28 ES ES17742782T patent/ES2751154T3/es active Active
- 2017-07-28 HR HRP20191798TT patent/HRP20191798T1/hr unknown
- 2017-07-28 PL PL17742782T patent/PL3319601T3/pl unknown
-
2018
- 2018-03-26 US US15/935,695 patent/US10117854B2/en not_active Expired - Fee Related
- 2018-09-18 US US16/134,144 patent/US10328059B2/en not_active Expired - Fee Related
-
2019
- 2019-01-24 IL IL264460A patent/IL264460B/en active IP Right Grant
- 2019-11-18 CY CY20191101208T patent/CY1122348T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2751154T3 (es) | 2020-03-30 |
| CY1122348T1 (el) | 2021-01-27 |
| DK3319601T3 (da) | 2019-11-18 |
| HRP20191798T1 (hr) | 2019-12-27 |
| SMT201900628T1 (it) | 2020-01-14 |
| US10328059B2 (en) | 2019-06-25 |
| ME03520B (me) | 2020-04-20 |
| CA3031302A1 (en) | 2018-02-01 |
| EP3275439A1 (en) | 2018-01-31 |
| IL264460B (en) | 2021-06-30 |
| AU2017303346A1 (en) | 2019-01-31 |
| KR20190034550A (ko) | 2019-04-02 |
| EP3319601B1 (en) | 2019-08-28 |
| HK1254833B (en) | 2020-05-22 |
| EA201990413A1 (ru) | 2019-06-28 |
| PL3319601T3 (pl) | 2020-06-29 |
| LT3319601T (lt) | 2019-11-11 |
| PT3319601T (pt) | 2019-09-18 |
| WO2018020010A1 (en) | 2018-02-01 |
| JP2019522030A (ja) | 2019-08-08 |
| US10117854B2 (en) | 2018-11-06 |
| US20190070150A1 (en) | 2019-03-07 |
| MA42419B1 (fr) | 2019-11-29 |
| EP3319601A1 (en) | 2018-05-16 |
| HUE046590T2 (hu) | 2020-03-30 |
| SI3319601T1 (sl) | 2019-11-29 |
| RS59300B1 (sr) | 2019-10-31 |
| IL264460A (en) | 2019-02-28 |
| US20180214417A1 (en) | 2018-08-02 |
| MA42419A (fr) | 2018-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022007607A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostericos de shp2. | |
| CL2018000070A1 (es) | Modulares de diaciglicerol aciltransderasa 2 (dgta2) | |
| CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
| BR112017017217A2 (pt) | ?composição que compreende ramnolipídeo e siloxano? | |
| DOP2017000109A (es) | Derivados de feniltriazol sustituido con hidroxialquilo y sus usos | |
| BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
| CO2021004141A2 (es) | Moduladores de la expresión de pnpla3 | |
| CO2019011265A2 (es) | Moduladores de la expresión de pcsk9 | |
| CO2019008103A2 (es) | Composiciones farmacéuticas para terapia de combinación | |
| BR112017028048A2 (pt) | drospirenona como o único ingrediente contraceptivo para uso | |
| MX386055B (es) | Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson. | |
| CO2020008769A2 (es) | Moduladores de la expresión dnm2 | |
| CL2016002151A1 (es) | Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico | |
| MX2018010683A (es) | Compuestos de seleno-galactosida para la prevención y el tratamiento de las enfermedades asociadas con galectina y el uso de los mismos. | |
| BR112019001178A2 (pt) | biotinas e composição de biotina | |
| MX2017009929A (es) | Composiciones y métodos para metabolismo muscular mejorado. | |
| BR112016008901A2 (pt) | Compostos para uso na prevenção e tratamento de doenças neurodegenerativas e da dor. | |
| CL2021000660A1 (es) | Compuestos quelantes de hierro para tratar condiciones estéticas de la piel | |
| BR112017018618A2 (pt) | odorizante de osmanthus | |
| MX386393B (es) | Andrografólido para tratar formas progresivas de esclerosis múltiple. | |
| CO2020003134A2 (es) | Moduladores de la expresión de enac | |
| MX2017011904A (es) | Composiciones para el tratamiento de fibrosis y afecciones relacionadas con fibrosis. | |
| MX2017004909A (es) | Composiciones de triptamina y metodos de uso. | |
| CO2019007671A2 (es) | Una composición farmacéutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevención de la enfermedad de alzheimer | |
| MX384394B (es) | Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2681 DE 24-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |